Manufacturer of Neomycin and Polymyxin B Sulfates and Hydrocortisone Ophthalmic Ointment

The contract entails the manufacturing or private-label production of an ophthalmic ointment containing Neomycin and Polymyxin B Sulfates and Hydrocortisone, specifically aligned with the National Stock Number 6505010430230 for supply to U.S. government agencies. Production must adhere strictly to current Good Manufacturing Practices and FDA regulatory standards to ensure product safety, efficacy, and consistency. The work is structured as a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with the North American Industry Classification System code 325412 indicating pharmaceutical manufacturing. The product is intended for official procurement and distribution, requiring full compliance with all federal quality and documentation requirements. The solicitation was posted on August 1, 2026, and performance is expected to meet the stringent demands of military and defense medical supply chains without specification of a geographic place of performance or set-aside conditions.